Use of recombinant HCV antigen in the serodiagnosis of hepatitis C virus infection: Significant improvement in HCV antibody detection as compared with the first generation HCV C100‐3 ELISA and the synthetic peptide EIA tests

CHIEN D.Y.CHOO Q.‐L.TABRIZI A.KUO C.McFARLAND J.BERGER K.Lee, Cha-ZeCha-ZeLeeSHUSTER J.R.NGUYEN T.MOYER D.L.TONG M.FURUTA S.OMATA M.FONG C.T.TEGTMEIER G.ALTER H.SCHIFF E.JEFFERS L.HOUGHTON M.KUO G.2021-02-022021-02-0219930815-9319https://www.scopus.com/inward/record.uri?eid=2-s2.0-84993907119&doi=10.1111%2fj.1440-1746.1993.tb01679.x&partnerID=40&md5=3ffcc39521b96abf49c728bd8c815393https://scholars.lib.ntu.edu.tw/handle/123456789/545871[SDGs]SDG3Use of recombinant HCV antigen in the serodiagnosis of hepatitis C virus infection: Significant improvement in HCV antibody detection as compared with the first generation HCV C100‐3 ELISA and the synthetic peptide EIA testsjournal article10.1111/j.1440-1746.1993.tb01679.x2-s2.0-84993907119